ArticleAnnals of medicine and surgery (2012)2026
A 65-year-old male with phosphaturic mesenchymal tumor presenting as tumor-induced osteomalacia: a case report.
Article in Annals of medicine and surgery (2012), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Tumor-induced osteomalacia (TIO) is a rare paraneoplastic disorder caused by phosphaturic mesenchymal tumors (PMTs), characterized by chronic hypophosphatemia and impaired bone mineralization. Case presentation: A 65-year-old man presented with progressive bone pain lasting 3 years. Laboratory results showed persistent hypophosphatemia and elevated fibroblast growth factor 23. Imaging revealed a hypermetabolic lesion in the left acetabulum. The tumor was surgically resected, and histology confirmed a spindle cell neoplasm without vascular invasion. Serum phosphorus normalized postoperatively, and the patient showed sustained clinical improvement over 1 year. Clinical discussion: This case underscores the diagnostic challenges of TIO, often mimicking other metabolic bone diseases and leading to significant delays. Compared with similar reports, our case highlights the utility of combined positron emission tomography and magnetic resonance imaging in localizing PMTs and the dramatic clinical improvement following resection. Conclusion: This case underscores the importance of recognizing TIO early to enable effective treatment and avoid prolonged morbidity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.